期刊文献+

P-AKT、FASN蛋白与骨肉瘤的相关性研究 被引量:1

The study of relationship between P-AKT and FASN in osteosarcoma
下载PDF
导出
摘要 目的探讨骨肉瘤组织中P-AKT及FASN中的表达情况及其与预后的关系。方法采用免疫组织化学方法及Western blot法检测P-AKT、FASN在50例骨巨细胞瘤组织及50例骨肉瘤组织中的表达,并分别分析其与预后的关系。结果免疫组织化学结果显示,P-AKT在骨巨细胞瘤中的阳性表达率为62.00%,显著低于其在骨肉瘤中的表达80%。FASN在骨巨细胞瘤中的阳性表达率为26%,显著低于其在骨肉瘤中的表达62%(P<0.05)。Western blot检测结果与免疫组织化学结果一致。直线相关分析显示,P-AKT的表达与软组织浸润及转移密切相关,FASN的表达与软组织浸润相关;直线相关显示,P-AKT及FASN的表达呈显著正相关。结论P-AKT的表达与软组织浸润及转移密切相关,FASN的表达与软组织浸润相关,且均在骨肉瘤中表达上调,提示两种基因可能与骨肉瘤的发生发展有关。 Objective This work aimed to investigate the relationship between P-AKT and FASN in osteosarcoma. Methods SP immunohistochemical and Western blot analysis were used to detect the expression of P-AKT and FASN in osteosarcoma (50 cases)and giant cell tumor of bone (50 cases), and their relationships to clinical and pathological factors were analyzed. Results IHC showed that P-AKT was expressed in 62.00% (31/50) of giant cell tumors,which was lower than that in osteosarcoma (80%)(40/ 50) (P 〈 0.05). FASN was expressed in 26% (13/50) of giant cell tumors, which was lower than that in osteosarcoma (62%)(31/50) (P 〈 0.05), the same results were observed in Western blot. The expression P-AKT was correlated with soft tissue invasion and metastasis, and FASN was correlated with metastasis. There was a positive relationship between the expression of P-AKT and FASN in the same sample. Conclusion The expression of P-AKT is correlated with soft tissue invasion and metastasis, and FASN correlated with metastasis and is highly expressed in osteosarcoma, which suggests that P-AKT and FASN may promote the genesis and development of osteosarcoma.
作者 仇海军 王军 Qiu Haijun Wang Jun(The Second Department of Surgery Chengde Courty Chinese Traditonal Medical Hospital,ChengDe 067400,Chin)
出处 《中华保健医学杂志》 2016年第6期448-450,共3页 Chinese Journal of Health Care and Medicine
基金 承德市科学研究与发展计划项目(20132408)
关键词 P—AKT 脂肪酸合成酶 骨肉瘤 骨巨细胞瘤 P-AKT FASN Osteosarcoma Giant cell tumors
  • 相关文献

参考文献6

二级参考文献52

  • 1张大勇,黄中新.Sonic hedgehog信号通路在肺发育及肺癌发生中的意义[J].解剖学研究,2007,29(1):68-72. 被引量:1
  • 2宋彦,王科峰,宋永胜.脂肪酸合成酶在膀胱移行细胞癌组织中的表达及其临床意义[J].中国癌症杂志,2007,17(5):395-397. 被引量:3
  • 3温星桥,李小娟,罗云,王林,周祥福,蔡育彬,温机灵,高新.生育酚结合蛋白通过磷酸肌醇3激酶途径抑制前列腺癌的生长[J].中山大学学报(医学科学版),2007,28(4):367-372. 被引量:4
  • 4Shamji AF, Nghiem P, Schreiber SI,. Integration of growth factor anti nutrient signaling: implications for cancer biology [ J ]. Mol Cell, 2003,12 (2) : 271-280.
  • 5Ayanta D, Stephanie JW, Joan SB. Akt activation disrupts mammary aeinar architecture and enhances proliferation in an mTOR-dependent manner [ J]. J Cell Biol, 2003,163(2) :315-326.
  • 6Lin H J, Hsieh FC, Song H, et al. Elevated phosphorylation and activation of PDK-1/AKT pathway in human breast cancer [J]. Br J Cancer, 2005,93 (12) : 1372-1381.
  • 7Tsurutani J, West KA, Sayyah J, et al. Inhibition of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway but not the MEK/ERK pathway attenuates laminin-mediated small cell lung cancer cellular survival and resistance to imatinih mesylate or chemotherapy [J]. Cancer Res, 2005,65 (18) :8423- 8432.
  • 8Takeuchi H, Kondo Y, Fujiwara K, et al. Synergistic augmentation of rapamycin-induced autophagy in malignant glioma cells by phosphatidylinositol 3-kinase/ protein kinase B inhibitors [J]. Cancer Res, 2005,65 (8) :3336-3346.
  • 9Keith CT, Schreiber SL. PIK-related kinases: DNA repair, recombination, and cell cycle checkpoint [J]. Science, 1995,270(5233) :50-51.
  • 10Bjornsti MA, Houghton PJ. The TOR pathway: a target for cancer therapy [J]. Nat rev Cancer, 2004,4(5): 335-348.

共引文献42

同被引文献14

引证文献1

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部